Alzamend Neuro Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.02

-0.01 (-0.97%)

As of May 16, 2:32 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +3,715.7% upside

Low Target $24.59

Average Target $38.92

High Target $51.00

Current Price $1.02

Current
$1.02

Target
$38.92

$24.59 $38.92 avg $51.00

Scenario Analysis

Bear Case

$24.59

2,310.8%

Low target

Base Case

$38.92

+3,715.7%

Avg target

Bull Case

$51.00

+4,900.0%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$8.22

-87.6% from high

52-Week Low

$0.84

+21.4% from low

Target vs 52W High

$38.92

+373.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%